Evaluation of Serum Posaconazole Concentrations in Patients with Hematological Malignancies Receiving Posaconazole Suspension Compared to the Delayed-Release Tablet Formulation

Posaconazole (PCZ) is frequently used for prophylaxis against invasive fungal infections (IFI) in patients undergoing induction chemotherapy for acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Posaconazole is commercially available as an oral suspension (PCZ-susp) and as a delayed-re...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Leuk Res Treatment
Main Authors: Belling, Morgan, Kanate, Abraham S., Shillingburg, Alexandra, Lu, Xiaoxiao, Wen, Sijin, Shah, Nilay, Craig, Michael, Cumpston, Aaron
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi 2017
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5485328/
https://ncbi.nlm.nih.gov/pubmed/28695013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/3460892
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares